Abstract
Little is known about psychological distress among women of African descent who are at high risk for a BRCA mutation. This is a group for whom breast cancer risk reduction is critical due to the group’s high rates of breast cancer mortality. Distress is important to consider as it may reduce the potential benefit of genetic counseling and negatively affect decision making related to risk reduction. The goals of the current study were to examine breast cancer-specific distress and depressive symptoms in women of African descent at who are at high risk for a BRCA mutation and to identify background factors associated with these outcomes. Participants were 148 high-risk African American and Caribbean women who were part of a larger study that offered participants BRCA counseling at no cost. Participants completed the Impact of Events Scale, which assessed breast cancer-specific distress, and the Center of Epidemiological Studies-Depression Scale, which assessed depressive symptoms. Results of analyses revealed that almost half of the sample achieved scores indicating high and clinically significant breast cancer-specific distress, while almost one-third had clinically significant depression scores. Results further showed that low income was significantly associated with cancer-specific distress, while having a cancer diagnosis was significantly associated with depressive symptoms. These results underscore the need for targeted psychological support throughout the genetic risk assessment process for this particular high-risk group.
Similar content being viewed by others
References
American Cancer Society. (2011). Cancer Facts & Figures for African Americans 2011–2012. Atlanta: American Cancer Society.
Armstrong, K., Weber, B., Stopfer, J., Calzone, K., Putt, M., Coyne, J., et al. (2003). Early use of clinical BRCA1/2 testing: Associations with race and breast cancer risk. American Journal of Medical Genetics. Part A, 117A(2), 154–160.
Audrain, J., Schwartz, M. D., Lerman, C., Hughes, C., Peshkin, B. N., & Biesecker, B. (1997). Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal. Annals of Behavioral Medicine, 19(4), 370–377.
Belle Doucet, D. J. (2003). Poverty, Inequality, And Discrimination As Sources Of Depression Among U.S. Women. Psychology of Women Quarterly, 27(2), 101–113.
Bober, S. L., Hoke, L. A., Duda, R. B., Regan, M. M., & Tung, N. M. (2004). Decision-Making About Tamoxifen in Women at High Risk for Breast Cancer: Clinical and Psychological Factors. Journal of Clinical Oncology, 22(24), 4951–4957.
Brown, K. L., Moglia, D. M., & Grumet, S. (2006). Genetic counseling for breast cancer risk: general concepts, challenging themes and future directions. Breast Disease, 27, 69–96.
Butow, P., Meiser, B., Price, M., Bennett, B., Tucker, K., Davenport, T., et al. (2005). Psychological morbidity in women at increased risk of developing breast cancer: a controlled study. Psycho-Oncology, 14(3), 196–203.
Campeau, P. M., Foulkes, W. D., & Tischkowitz, M. D. (2008). Hereditary breast cancer: new genetic developments, new therapeutic avenues. Human Genetics, 124(1), 31–42.
Coiro, M. J. (2001). Depressive Symptoms Among Women Receiving Welfare. Women & Health, 32(1), 1–23.
Coyne, J. C., Benazon, N. R., Gaba, C. G., Calzone, K., & Weber, B. L. (2000). Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families. Journal of Consulting and Clinical Psychology, 68(5), 864–874.
Cull, A., Anderson, E. D., Campbell, S., Mackay, J., Smyth, E., & Steel, M. (1999). The impact of genetic counselling about breast cancer risk on women’s risk perceptions and levels of distress. British Journal of Cancer, 79(3–4), 501–508.
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression Is a Risk Factor for Noncompliance With Medical Treatment: Meta-analysis of the Effects of Anxiety and Depression on Patient Adherence. Archives of Internal Medicine, 160(14), 2101–2107.
Duric, V., Butow, P., Sharpe, L., Lobb, E., Meiser, B., Barratt, A., et al. (2003). Reducing Psychological Distress in a Genetic Counseling Consultation for Breast Cancer. Journal of Genetic Counseling, 12(3), 243–264.
Easton, D. F., Ford, D., & Bishop, D. T. (1995). Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. American Journal of Human Genetics, 56(1), 265–271.
Force*, U. S. P. S. T. (2005). Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement. Annals of Internal Medicine, 143(5), 355–361.
Garssen, B., & Goodkin, K. (1999). On the role of immunological factors as mediators between psychosocial factors and cancer progression. Psychiatry Research, 85(1), 51–61. doi:https://doi.org/10.1016/S0165-1781(99)00008-6.
Gronwald, J., Tung, N., Foulkes, W. D., Offit, K., Gershoni, R., Daly, M., et al. (2006). Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. International Journal of Cancer, 118(9), 2281–2284.
Halbert, C., Kessler, L., Collier, A., Paul Wileyto, E., Brewster, K., & Weathers, B. (2005). Psychological functioning in African American women at an increased risk of hereditary breast and ovarian cancer. Clinical Genetics, 68(3), 222–227.
Hall, M. J., & Olopade, O. I. (2006). Disparities in genetic testing: thinking outside the BRCA box. Journal of Clinical Oncology, 24(14), 2197–2203.
Hasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005). Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Archives of General Psychiatry, 62(10), 1097–1106.
Helgeson, V. S., Snyder, P., & Seltman, H. (2004). Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychology, 23(1), 3–15.
Heshka, J. T., Palleschi, C., Howley, H., Wilson, B., & Wells, P. S. (2008). A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genetics in Medicine, 10(1), 19–32.
Hopwood, P., Keeling, F., Long, A., Pool, C., Evans, G., & Howell, A. (1998). Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psycho-Oncology, 7(5), 402–412.
Horowitz, M., Wilner, N., & Alvarez, W. (1979). Impact of Event Scale: a measure of subjective stress. Psychosomatic Medicine, 41(3), 209–218.
Horowitz, M. J., Wilner, N., Kaltreider, N., & Alvarez, W. (1980). Signs and symptoms of posttraumatic stress disorder. Archives of General Psychiatry, 37(1), 85–92.
Hurt, G. J., McQuellon, R. P., & Barrett, R. J. (1994). After treatment ends: neutral time. Cancer Practice, 2(6), 417–420.
King, M. C., Wieand, S., Hale, K., Lee, M., Walsh, T., Owens, K., et al. (2001). Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA, 286(18), 2251–2256.
Kodl, M., Lee, J., Matthews, A., Cummings, S., & Olopade, O. (2006). Correlates of Depressive Symptoms Among Women Seeking Cancer Genetic Counseling and Risk Assessment at a High-Risk Cancer Clinic. Journal of Genetic Counseling, 15(4), 267–276.
Kornblith, A. B., & Ligibel, J. (2003). Psychosocial and sexual functioning of survivors of breast cancer. Seminars in Oncology, 30(6), 799–813.
Lerman, C., Lustbader, E., Rimer, B., Daly, M., Miller, S., Sands, C., et al. (1995). Effects of individualized breast cancer risk counseling: a randomized trial. Journal of the National Cancer Institute, 87(4), 286–292.
Lindberg, N. M., & Wellisch, D. K. (2004). Identification of Traumatic Stress Reactions in Women at Increased Risk for Breast Cancer. Psychosomatics, 45(1), 7–16.
Myers, M. F., Chang, M. H., Jorgensen, C., Whitworth, W., Kassim, S., Litch, J. A., et al. (2006). Genetic testing for susceptibility to breast and ovarian cancer: evaluating the impact of a direct-to-consumer marketing campaign on physicians’ knowledge and practices. Genetics in Medicine, 8(6), 361–370.
Narod, S. A., Brunet, J. S., Ghadirian, P., Robson, M., Heimdal, K., Neuhausen, S. L., et al. (2000). Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case–control study. Hereditary Breast Cancer Clinical Study Group. Lancet, 356(9245), 1876–1881.
NCCN practice guidelines for the management of psychosocial distress. National Comprehensive Cancer Network. (1999). Oncology (Williston Park), 13(5A), 113–147.
Palma, M., Ristori, E., Ricevuto, E., Giannini, G., & Gulino, A. (2006). BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers. Critical Reviews in Oncology/Hematology, 57(1), 1–23.
Pratt, L. A., & Brody, D. J. (2008). Depression in the United States household population, 2005–2006. NCHS Data Brief, 7, 1–8.
Radloff, L. S. (1977). The CES-D Scale: A Self-Report Depression Scale for Research in the General Population. Applied Psychological Measurement, 1(3), 385–401.
Saleeba, A. K., Weitzner, M. A., & Meyers, C. A. (1996). Subclinical Psychological Distress in Long-Term Survivors of Breast Cancer—A Preliminary Communication. Journal of Psychosocial Oncology, 14(1), 83–93.
Siefert, K., Williams, D. R., Finlayson, T. L., Delva, J., & Ismail, A. I. (2007). Modifiable Risk and Protective Factors for Depressive Symptoms in Low-Income African American Mothers. The American Journal of Orthopsychiatry, 77(1), 113–123.
Stefanek, M. E., Helzlsouer, K. J., Wilcox, P. M., & Houn, F. (1995). Predictors of and satisfaction with bilateral prophylactic mastectomy. Preventive Medicine, 24(4), 412–419.
Thewes, B., Meiser, B., & Hickie, I. B. (2001). Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer. Psycho-Oncology, 10(6), 459–468.
Thompson, H. S., Valdimarsdottir, H. B., Duteau-Buck, C., Guevarra, J., Bovbjerg, D. H., Richmond-Avellaneda, C., et al. (2002). Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemiology, Biomarkers & Prevention, 11(12), 1579–1585.
Wellisch, D. K., & Lindberg, N. M. (2001). A Psychological Profile of Depressed and Nondepressed Women at High Risk for Breast Cancer. Psychosomatics, 42(4), 330–336.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cukier, Y.R., Thompson, H.S., Sussner, K. et al. Factors Associated with Psychological Distress among Women of African Descent at High Risk for BRCA Mutations. J Genet Counsel 22, 101–107 (2013). https://doi.org/10.1007/s10897-012-9510-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-012-9510-1